Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EXPO
EXPO logo

EXPO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Exponent Inc (EXPO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
66.560
1 Day change
2.35%
52 Week Range
83.920
Analysis Updated At
2026/04/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Exponent Inc (EXPO) is not a strong buy for a beginner, long-term investor at the moment. While the company has shown steady financial growth and analysts see potential upside, the lack of significant positive catalysts, insider selling, and bearish technical indicators suggest waiting for a better entry point.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 66.038, with resistance at 68.351 and support at 63.725. This suggests limited immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
5

Positive Catalysts

  • The company's financials show steady growth in revenue (+4.54% YoY), net income (+4.97% YoY), and EPS (+6.52% YoY). Analysts like JPMorgan see long-term upside potential with a price target of $95, citing strong fundamentals and a rebound in growth.

Neutral/Negative Catalysts

  • Insiders are selling heavily, with a 370.29% increase in selling activity over the last month. There are no recent news catalysts, and hedge funds are neutral on the stock. The bearish moving averages and lack of significant trading signals further dampen the immediate outlook.

Financial Performance

In Q4 2025, Exponent reported revenue of $129.38M (+4.54% YoY), net income of $24.76M (+4.97% YoY), and EPS of $0.49 (+6.52% YoY). Gross margin remained stable at 100%. These figures indicate consistent but modest growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed but leaning positive. JPMorgan maintains an Overweight rating with a price target of $95, citing strong fundamentals and growth potential. UBS raised its price target to $85 but maintains a Neutral rating, noting conservative guidance and potential upside.

Wall Street analysts forecast EXPO stock price to rise
3 Analyst Rating
Wall Street analysts forecast EXPO stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 65.030
sliders
Low
81
Averages
85.5
High
90
Current: 65.030
sliders
Low
81
Averages
85.5
High
90
JPMorgan
NULL -> Overweight
maintain
$100 -> $95
AI Analysis
2026-03-26
Reason
JPMorgan
Price Target
$100 -> $95
AI Analysis
2026-03-26
maintain
NULL -> Overweight
Reason
JPMorgan lowered the firm's price target on Exponent to $95 from $100 and keeps an Overweight rating on the shares. The firm updated models in the North American small-cap industrials sector. The group is "undergoing a strategic rebalance, driven by evolving market dynamics and sector-specific growth opportunities," the analyst tells investors in a research note.
UBS
Joshua Chan
Neutral
maintain
$81 -> $85
2026-02-09
Reason
UBS
Joshua Chan
Price Target
$81 -> $85
2026-02-09
maintain
Neutral
Reason
UBS analyst Joshua Chan raised the firm's price target on Exponent to $85 from $81 and keeps a Neutral rating on the shares. The Q4 results and 2026 guidance were largely consistent with consensus, but given that guidance typically leans conservative, there could be perceived upside potential through the year against a stock that has de-rated over much of the past year, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EXPO
Unlock Now

People Also Watch